
Hims & Hers Health, Inc.: stock overview
Price
$19.73
November 13, 2026Market cap $4.4B
What Ploutos Investor adds for Hims & Hers Health
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
In short
Hims & Hers Health had revenue of $2.9B over the last 12 months and a net loss of $191M. Revenue grew by 73.6% a year on average over the last 5 years. It has net debt of $655M. It pays no dividend.
From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $4.4B
- 225M shares
- P/E
- –
- Revenue, 12 months
- $2.9B
- +73.6% a year over 5 years
- Net margin
- -6.7%
- 2025: 5.5%, above 73% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
+64.1% a year over 2 years
Fiscal years in figures
HIMS's revenue, profit, cash flow and dividend with each year-end price, from 2019 to 2022, 4 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $5.2B
- $4.4B
- Enterprise value
- $5.1B
- P/E
- –
- EV / EBIT
- –
- EV / Revenue
- 1.8
- P/B 3-year median: 11.0
- 12.5
- FCF yield 3-year median: 2.5%
- 0.2%
- Earnings yield 3-year median: 1.6%
- –
Profitability
- Gross margin
- 63.8%
- Operating margin
- -8.1%
- Net margin 3-year median: 5.5%
- -6.7%
- ROIC
- -11.6%
- ROIC, 5-year average
- -7.1%
- ROE
- -42.5%
Growth
- Revenue, yearly change
- +59.0%
- EPS, yearly change
- -3.8%
- FCF, yearly change
- -71.1%
- Revenue, average a year
- +73.6%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $712M
- Total debt
- $1.6B
- Of which operating leases
- $193M
- Net debt
- $655M
- Net debt / EBITDA
- –
- Interest cover
- –
- Current ratio
- 0.92
Balance sheet of September 30, 2026.
Returns to shareholders
- Dividend yield
- 0.00%
- Buybacks
- 2.03%
- Total returned
- 2.03%
- Shares, yearly change
- +4.2%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 80).
Gross margin
73.8%
Above 90% of the 25 companies in its industry, and 89% of all.
Operating margin
4.5%
Above 57% of the 62 companies in its industry, and 49% of all.
Net margin
5.5%
Above 73% of the 68 companies in its industry, and 54% of all.
ROE
23.7%
Above 94% of the 58 companies in its industry, and 88% of all.
ROA
6.0%
Above 73% of the 69 companies in its industry, and 76% of all.
Revenue growth
59.0%
Above 96% of the 68 companies in its industry, and 95% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- Hims & Hers Health, Inc.
- CIK
- 1773751
- Exchange
- NYSE
- Industry (SIC)
- 8011 · Services-Offices & Clinics of Doctors of Medicine
- Fiscal year ends
- December 31
- Latest annual report
- December 31, 2025
- Reporting currency
- USD
- Shares
- 225M
Other companies: Healthcare
The largest companies of the same sector, each with its own page.
- LLYEli Lilly and Company+0,00%Compare with HIMS
- JNJJohnson & Johnson+0,00%Compare with HIMS
- ABBVAbbVie+0,00%Compare with HIMS
- UNHUnitedHealth+0,00%Compare with HIMS
- MRKMerck & Company+0,00%Compare with HIMS
- AMGNAmgen+0,00%Compare with HIMS
- TMOThermo Fisher Scientific+0,00%Compare with HIMS
- ABTAbbott Laboratories+0,00%Compare with HIMS
The full analysis
What do Hims & Hers Health's filings show?
These are Hims & Hers Health's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is HIMS's market cap?
Hims & Hers Health, Inc.'s market cap is $4.4B, at a price of $19.73 on November 13, 2026 and 225M shares.
How much revenue does HIMS have?
Hims & Hers Health had revenue of $2.9B over the last 12 months. Over the last 5 years it changed by +73.6% a year on average.
Does HIMS pay a dividend?
No. Hims & Hers Health paid no regular dividend over the last 12 months.
Where do the figures come from?
From Hims & Hers Health, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.